BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28575138)

  • 1. Elevated Plasma Transforming Growth Factor β1 Levels Predict the Development of Hypertension in Normotensives: The 14-Year Follow-Up Study.
    Nakao E; Adachi H; Enomoto M; Fukami A; Kumagai E; Nakamura S; Nohara Y; Kono S; Sakaue A; Morikawa N; Tsuru T; Fukumoto Y
    Am J Hypertens; 2017 Aug; 30(8):808-814. PubMed ID: 28575138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum transforming growth factor β
    Liu Y; Lin Y; Huang X; Li Y; Liu Y; Shi L
    Eur J Pediatr; 2023 Dec; 182(12):5439-5446. PubMed ID: 37755472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of transforming growth factor-beta1 in essential hypertension.
    Derhaschnig U; Shehata M; Herkner H; Bur A; Woisetschläger C; Laggner AN; Hirschl MM
    Am J Hypertens; 2002 Mar; 15(3):207-11. PubMed ID: 11939608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the TGFBRAP1 gene in relation to blood pressure variability and plasma TGF-β1.
    Guo D; Shen C; Chen Y; Yang S; Wang L; Jin Y; He L; Chen J; Zhao X; Zhou W; Zhao H; Yao Y
    Clin Exp Hypertens; 2015; 37(5):420-5. PubMed ID: 25856002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in serum transforming growth factor-beta1 levels with gender, age and lifestyle factors of healthy Japanese adults.
    Lin Y; Nakachi K; Ito Y; Kikuchi S; Tamakoshi A; Yagyu K; Watanabe Y; Inaba Y; Kazuo Tajima ;
    Dis Markers; 2009; 27(1):23-8. PubMed ID: 19822955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta1 DNA polymorphisms, protein levels, and blood pressure.
    Li B; Khanna A; Sharma V; Singh T; Suthanthiran M; August P
    Hypertension; 1999 Jan; 33(1 Pt 2):271-5. PubMed ID: 9931116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of plasma transforming growth factor-β1 in idiopathic and heritable pulmonary arterial hypertension.
    Yan Y; Wang XJ; Li SQ; Yang SH; Lv ZC; Wang LT; He YY; Jiang X; Wang Y; Jing ZC
    Int J Cardiol; 2016 Nov; 222():368-374. PubMed ID: 27500766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of losartan on left ventricular hypertrophy and plasma transforming growth factor-beta1 in elderly patients with hypertension].
    Wu ZL; Xu DL; Li Y; Lai WY; Huang P; Bai SC; Su L
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):531-3. PubMed ID: 19304546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum transforming growth factor-beta1 levels and pancreatic cancer risk: a nested case-control study (Japan).
    Lin Y; Kikuchi S; Tamakoshi A; Obata Y; Yagyu K; Inaba Y; Kurosawa M; Kawamura T; Motohashi Y; Ishibashi T;
    Cancer Causes Control; 2006 Oct; 17(8):1077-82. PubMed ID: 16933058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker.
    Zhu S; Liu Y; Wang L; Meng QH
    Nephrol Dial Transplant; 2008 Sep; 23(9):2841-6. PubMed ID: 18390891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1 levels in hypertensive patients: association with body mass index and leptin.
    Porreca E; Di Febbo C; Vitacolonna E; Baccante G; Di Castelnuovo A; Angelini A; Febo F; Di Nisio M; Cuccurullo F
    Am J Hypertens; 2002 Sep; 15(9):759-65. PubMed ID: 12219869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease.
    Schaan BD; Quadros AS; Sarmento-Leite R; De Lucca G; Bender A; Bertoluci M
    Cardiovasc Diabetol; 2007 Jul; 6():19. PubMed ID: 17651487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level of plasma remnant-like particle cholesterol may predispose to development of hypertension in normotensive subjects.
    Kasahara A; Adachi H; Hirai Y; Enomoto M; Fukami A; Yoshikawa K; Esaki E; Yokoi K; Ogata K; Tsukagawa E; Obuchi A; Yoshimura A; Nakamura S; Imaizumi T
    Am J Hypertens; 2013 Jun; 26(6):793-8. PubMed ID: 23403840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between serum transforming growth factor-beta 1 and cancer mortality risk in a nested case-control study in Japan.
    Lin Y; Nakachi K; Ito Y; Kikuchi S; Tamakoshi A; Yagyu K; Watanabe Y; Inaba Y; Tajima K;
    Asian Pac J Cancer Prev; 2009; 10(2):273-8. PubMed ID: 19537896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years.
    Strand AH; Gudmundsdottir H; Os I; Smith G; Westheim AS; Bjørnerheim R; Kjeldsen SE
    J Hypertens; 2006 May; 24(5):905-13. PubMed ID: 16612253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming Growth Factor-β1 as a Predictor for the Development of Hepatocellular Carcinoma: A Nested Case-Controlled Study.
    Watanabe Y; Iwamura A; Shimada YJ; Wakai K; Tamakoshi A; Iso H;
    EBioMedicine; 2016 Oct; 12():68-71. PubMed ID: 27614396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma transforming growth factor-beta1 level in patients with severe community-acquired pneumonia and association with disease severity.
    Wu HP; Chen CK; Chung K; Jiang BY; Yu TJ; Chuang DY
    J Formos Med Assoc; 2009 Jan; 108(1):20-7. PubMed ID: 19181604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between transforming growth factor-beta(1) and left ventricular mass and diameter in hypertensive patients.
    Almendral JL; Shick V; Rosendorff C; Atlas SA
    J Am Soc Hypertens; 2010; 4(3):135-41. PubMed ID: 20470998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies.
    Jacobs EJ; Newton CC; Silverman DT; Nogueira LM; Albanes D; Männistö S; Pollak M; Stolzenberg-Solomon RZ
    Cancer Causes Control; 2014 Sep; 25(9):1083-91. PubMed ID: 24913781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta1 is associated with the progression of intracranial deep white matter lesions: a pilot study with 5 years of magnetic resonance imaging follow-up.
    Kuriyama N; Mizuno T; Kita M; Yamada K; Ozaki E; Matsumoto S; Takada A; Watanabe A; Kasai T; Nagakane Y; Mitani S; Matsui D; Watanabe I; Takeda K; Nakagawa M; Watanabe Y
    Neurol Res; 2014 Jan; 36(1):47-52. PubMed ID: 24083683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.